Semi-Annual Statement Of Income

K Pharma,Inc. - Filing #7543382

Concept 2023-01-01 to
2023-06-30
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Semi-annual statement of income
Statement of income
Net sales
1,000,000,000 JPY
Cost of sales
90,000,000 JPY
Ordinary profit (loss)
651,026,000 JPY
-359,233,000 JPY
-220,892,000 JPY
Gross profit (loss)
910,000,000 JPY
Selling, general and administrative expenses
258,890,000 JPY
353,772,000 JPY
219,491,000 JPY
Extraordinary losses
36,497,000 JPY
31,293,000 JPY
8,226,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
651,109,000 JPY
-353,772,000 JPY
-219,491,000 JPY
Profit (loss) before income taxes
614,528,000 JPY
-390,526,000 JPY
-229,119,000 JPY
Income taxes - current
99,755,000 JPY
1,900,000 JPY
579,000 JPY
Non-operating income
7,000 JPY
52,000 JPY
1,000 JPY
Income taxes - deferred
JPY
-980,000 JPY
Non-operating income
Interest income
7,000 JPY
7,000 JPY
1,000 JPY
Income taxes
99,755,000 JPY
1,900,000 JPY
-400,000 JPY
Non-operating expenses
90,000 JPY
5,514,000 JPY
1,403,000 JPY
Profit (loss)
514,772,000 JPY
-392,427,000 JPY
-392,427,000 JPY
-392,427,000 JPY
-392,427,000 JPY
-228,718,000 JPY
-228,718,000 JPY
-228,718,000 JPY
-228,718,000 JPY
Non-operating expenses
Extraordinary losses
Impairment losses
36,497,000 JPY
31,293,000 JPY
8,226,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.